Prevalence and clinical significance of cardiovascular abnormalities in patients with the LEOPARD syndrome

Am J Cardiol. 2007 Aug 15;100(4):736-41. doi: 10.1016/j.amjcard.2007.03.093. Epub 2007 Jun 27.

Abstract

The aim of this study was to characterize cardiovascular involvement in a large number of patients with LEOPARD syndrome. Twenty-six patients (age range 0 to 63 years, median age at the time of the study evaluation 17 years) underwent clinical and genetic investigations. Familial disease was ascertained in 9 patients. Nineteen patients (73%) showed electrocardiographic abnormalities. Left ventricular (LV) hypertrophy was present in 19 patients (73%), including 9 with LV outflow tract obstructions; right ventricular hypertrophy was present in 8 patients (30%). Valve (57%) and coronary artery (15%) anomalies were also observed. Single patients showed LV apical aneurysm, LV noncompaction, isolated LV dilation, and atrioventricular canal defect. During follow-up (9.1 +/- 4.5 years), 2 patients died suddenly, and 2 patients had cardiac arrest. These patients had LV hypertrophy. Despite the limited number of subjects studied, genotype-phenotype correlations were observed in familial cases. In conclusion, most patients with LEOPARD syndrome showed LV hypertrophy, often in association with other valvular or congenital defects. A spectrum of underrecognized cardiac anomalies were also observed. Long-term prognosis was benign, but the occurrence of 4 fatal events in patients with LV hypertrophy indicates that such patients require careful risk assessment and, in some cases, consideration for prophylaxis against sudden death.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Cardiovascular Abnormalities* / complications
  • Cardiovascular Abnormalities* / epidemiology
  • Cardiovascular Abnormalities* / genetics
  • Child
  • Child, Preschool
  • DNA / genetics
  • Echocardiography
  • Electrocardiography, Ambulatory
  • Female
  • Follow-Up Studies
  • Genotype
  • Humans
  • Infant
  • Infant, Newborn
  • Intracellular Signaling Peptides and Proteins / genetics
  • Italy / epidemiology
  • LEOPARD Syndrome / complications*
  • LEOPARD Syndrome / diagnosis
  • LEOPARD Syndrome / genetics
  • Male
  • Middle Aged
  • Mutation
  • Polymerase Chain Reaction
  • Prevalence
  • Prognosis
  • Protein Tyrosine Phosphatase, Non-Receptor Type 11
  • Protein Tyrosine Phosphatases / genetics
  • Retrospective Studies
  • Risk Assessment
  • SH2 Domain-Containing Protein Tyrosine Phosphatases
  • Survival Rate
  • Time Factors
  • United Kingdom / epidemiology
  • src Homology Domains

Substances

  • Intracellular Signaling Peptides and Proteins
  • DNA
  • PTPN11 protein, human
  • Protein Tyrosine Phosphatase, Non-Receptor Type 11
  • Protein Tyrosine Phosphatases
  • SH2 Domain-Containing Protein Tyrosine Phosphatases